Taewon U. Lee

Sejong, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study.

Correction: Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study.

Journal: Cardiovascular toxicology

Published: January 12, 2026

A tumor-targeted heptamethine cyanine dye suppresses triple-negative breast cancer by induction of lethal autophagy.

A tumor-targeted heptamethine cyanine dye suppresses triple-negative breast cancer by induction of lethal autophagy.

Journal: Theranostics

Published: December 22, 2025

Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg).

Exploratory comparative pharmacokinetic study of a fixed-dose combination of telmisartan/amlodipine/chlorthalidone: half-dose (20/2.5/6.25 mg) versus conventional dose (40/5/12.5 mg).

Journal: Translational and clinical pharmacology

Published: December 05, 2025

Assessment of Pharmacokinetics and Food Effect of AD-109, a Novel Formulation of Rivaroxaban 18 mg.

Assessment of Pharmacokinetics and Food Effect of AD-109, a Novel Formulation of Rivaroxaban 18 mg.

Journal: Clinical and translational science

Published: August 05, 2025

Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study.

Exploring Predictive Risk Factors for Myocardial Injury in Children Treated with Anthracyclines: A Pilot Study.

Journal: Cardiovascular toxicology

Published: June 06, 2025

Pharmacokinetic comparison between the fixed-dose combination of rosuvastatin/ezetimibe 2.5/10 mg and the co-administration of individual formulations in healthy subjects.

Pharmacokinetic comparison between the fixed-dose combination of rosuvastatin/ezetimibe 2.5/10 mg and the co-administration of individual formulations in healthy subjects.

Journal: Translational and clinical pharmacology

Published: January 27, 2025

TMAA-net: tensor-domain multi-planal anti-aliasing network for sparse-view CT image reconstruction.

TMAA-net: tensor-domain multi-planal anti-aliasing network for sparse-view CT image reconstruction.

Journal: Physics in medicine and biology

Published: April 22, 2024

Innate Immune Training Initiates Efferocytosis to Protect against Lung Injury.

Innate Immune Training Initiates Efferocytosis to Protect against Lung Injury.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 21, 2023

Panoramic dental tomosynthesis imaging by use of CBCT projection data.

Panoramic dental tomosynthesis imaging by use of CBCT projection data.

Journal: Scientific reports

Published: November 18, 2022

MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicity.

MicroRNA-34a-5p as a promising early circulating preclinical biomarker of doxorubicin-induced chronic cardiotoxicity.

Journal: Journal of applied toxicology : JAT

Published: December 12, 2021

Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice.

Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice.

Journal: Journal of applied toxicology : JAT

Published: August 15, 2021

Production of Membrane Vesicles in Listeria monocytogenes Cultured with or without Sub-Inhibitory Concentrations of Antibiotics and Their Innate Immune Responses In Vitro.

Production of Membrane Vesicles in Listeria monocytogenes Cultured with or without Sub-Inhibitory Concentrations of Antibiotics and Their Innate Immune Responses In Vitro.

Journal: Genes

Published: February 03, 2021

Showing 1-12 of 31

Last Updated: 09/26/2026